You just read:

Forge Achieves CARB-X Milestone To Advance Its LpxC Antibiotic To Treat Infections Caused By The World's Deadliest 'Superbugs'

News provided by

Forge Therapeutics, Inc.

Aug 01, 2018, 08:00 ET